NASDAQ
Milestone Pharmaceuticals Inc. (MIST) has a free cash flow growth of -25.55% as of Friday, May 29, 2026. This represents a 0.48% decrease compared to its 12-month average of -25.43%. Free cash flow growth tracks the year-over-year percentage change in cash generated after capital expenditures.
No price data available for this timeframe.